Pfizer and Valneva have completed recruitment for a phase 3 trial of the Lyme disease vaccine VLA15 after work was halted earlier this year due to problems with one of the CROs at some of the trial ...

Roche has installed “stronger gates” to ensure that drug candidates only make it into phase 3 trials if they have a high likelihood of success, CEO Thomas Schinecker has revealed. Pointing to a slump ...

aTyr Pharma is a small-cap biotech focused on Efzofitimod for interstitial lung disease (ILD), a group of lung-scarring diseases. In 2021, the company completed a phase 1b/2a trial in pulmonary ...

Monoclonal antibodies that target amyloid-beta (Aβ) have the potential to slow cognitive and functional decline in persons with early Alzheimer’s disease. Gantenerumab is a subcutaneously administered ...

The study of the Cahn-Hilliard equation has long provided a robust framework for modelling phase separation in binary mixtures, with applications spanning materials science, tumour growth, and ...